Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 8, 2006, Pages 877-884

  Deupree, J D ^a   Smith, S D ^b   Kratochvil, C J ^b   Bohac, D ^b   Ellis, C R ^b   Polaha, J ^c   Bylund, D B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alpha 2 adrenoceptor; Association; Haplotypes; Linkage disequilibrium; Norepinephrine; Platelets

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; RADIOLIGAND; RECEPTOR PROTEIN;

ADOLESCENT; ADRA2A GENE; ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BINDING AFFINITY; CELL DENSITY; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRAI GENE; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HAPLOTYPE; HHAI GENE; HORMONE RECEPTOR INTERACTION; HUMAN; LIGAND BINDING; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MSPI GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOASSAY; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 33845409395     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30371     Document Type: Article

References (63)

1. Abecasis GR, Cardon LR, Cookson WO. 2000. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279-292.
2. Ambrosini PJ. 2000. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 39:49-58.
3. Arnsten AF. 2000. Genetics of childhood disorders: XVIII. ADHD, Part. 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 39:1201-1203.
4. Barr CL, Wigg K, Zai G, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL. 2001. Attention-deficit hyperactivity disorder and the adrenergic receptors alpha-1C and alpha-2C. Mol Psychiatry 6:334-337.
5. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R. 1992. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738.
6. Biederman J, Faraone SV, Monuteaux MC. 2002. Differential effect of environmental adversity by gender: Rutter's index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry 159:1556-1562.
7. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. 2004. Molecular genetic studies of ADHD: 1991 to 2005. Am J Med Genet B Neuropsychiatr Genet 132:109-125.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Bylund DB, Solomon N, Ray-Prenger C, Jones SB, Harris RA. 1984. Comparison of adrenergic receptor binding in blood cells from alcoholics and controls. Alcohol 1:369-372.
10. Bylund DB, Deupree JD, Toews ML. 2004. Radioligand binding methods for membrane preparations and intact cells. In: Willars GB, Challiss RA, editors. GPCR signal transduction protocols. Totowa, NJ: Humana Press, pp 1-28.
11. Cadoret RJ, Stewart MA. 1991. An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality. Compr Psychiatry 32:73-82.
12. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP. 1999. Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 55:160-172.
13. Comings DE, Gonzalez NS, Li S-CC, MacMurray J. 2003. A "line item" approach to the identification of genes involved in poly genie behavioral disorders: The Adrenergic alpha2A (ADRA2A) gene. Am J Med Genet Part B 1186:110-114.
14. Conners CK. 1997. Conners' Rating Scales-Revised: Technical Manual. North Towanda, New York: Multi-Health Systems, Inc.
15. De Luca V, Muglia P, Vincent JB, Lanktree M, Jain U, Kennedy JL. 2004. Adrenergic alpha 2C receptor genomic organization: Association study in adult ADHD. Am J Med Genet Part B 127B:65-67.
16. 3H]RX821002 to the alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 278:1215-1227.
17. DuPaul GJ, Anastopoulos AD, Power TJ, Reid R, Ikeda M, McGoey K. 1998. Parent ratings of attention-deficit disorder symptoms: Factor structure and normative data. J Psychopathol Behav Assess 20:83-102.
18. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. 2000. Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 48:9-20.
19. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
20. i protein in subjects with post-traumatic stress disorder and normal controls. Psychopharmacology (Berl) 141:258-266.
21. 3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers. Psychiatry Res 85:305-314.
22. i coupling, effects of imipramine and relationship to treatment outcome. Psychiatry Res 89:73-95.
23. Horvath S, Wei E, Xu X, Palmer LJ, Baur M. 2001. Family-based association test method: Age of onset traits and covariates. Genet Epidemiol 21 (Suppl 1):S403-S408.
24. Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD. 1995. Serotonergic markers in platelets of patients with major depression: Upregulation of 5-HT2 receptors. J Psychiatry Neurosci 20:11-19.
25. Ihalainen JA, Tanila H, Scheinin M, Riekkinen P Jr. 2001. Alpha-2C adrenoceptors modulate the effect of methylphenidate on response rate and discrimination accuracy in an operant test. Brain Res Bull 54:553-557.
26. Jones MD, Hess EJ. 2003. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 75:209-216.
27. Kanof PD, Johns CA, Davidson M, Siever LJ, Coccaro EF, Davis KL. 1988. Platelet alpha 2-adrenergic receptor function in psychiatric disorders. Psychiatry Res 23:11-22.
28. Karege F, Bovier P, Widmer J, Gaillard JM, Tissot R. 1992. Platelet membrane alpha 2-adrenergic receptors in depression. Psychiatry Res 43:243-252.
29. 3H]yohimbine binding to platelet alpha 2-adrenoceptors in depression. J Affect Disord 17:219-228.
30. Kent L. 2004. Recent advances in the genetics of attention deficit hyperactivity disorder. Curr Psychiatry Rep 6:143-148.
31. Lahdesmaki J, Sallinen J, MacDonald E, Scheinin M. 2004. Alpha-2A adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29:1282-1293.
32. Lange C. 2003. PBAT: Tools for family based association tests (FBAT). http://www.biostat.harvard.edu/~clange/default.htm.
33. Leo D, Sorrentino E, Volpicelli F, Eyman M, Greco D, Viggiano D, di PU, Perrone-Capano C. 2003. Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci Biobehav Rev 27:661-669.
34. Levy F, Hay DA, McStephen M, Wood C, Waldman I. 1997. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36:737-744.
35. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee SY, Levy F, Kent L, Middle F, Rohde LA, Roman T, Tahir E, Yazgan Y, Asherson P, Mill J, Thapar A, Payton A, Todd RD, Stephens T, Ebstein RP, Manor I, Barr CL, Wigg KG, Sinke RJ, Buitelaar JK, Smalley SL, Nelson SF, Biederman J, Faraone SV, Gill M. 2004. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 74:348-356.
36. Maes M, Van Gastel A, Delmeire L, Meltzer HY. 1999. Decreased platelet alpha-2 adrenoceptor density in major depression: Effects of tricyclic antidepressants and fluoxetine. Biol Psychiatry 45:278-284.
37. Moore J, Fombonne E. 1999. Psychopathology in adopted and nonadopted children: A clinical sample. Am J Orthopsychiatry 69:403-409.
38. Odagaki Y, Koyama T. 2002. Epinephrine- and thrombin-stimulated high-affinity GTPase activity in platelet membranes from patients with psychiatric disorders. Psychiatry Res 112:111-119.
39. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C, Cantor RM, McCracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. 2003. A genome wide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. Am J Hum Genet 72:1268-1279.
40. Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, Cantor RM, McCracken JT, McGough JJ, Smalley SL, Nelson SF. 2004. Attention deficit hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 75:661-668.
41. Park L, Nigg JT, Waldman ID, Nummy KA, Huang-Pollock C, Rappley M, Friderici KH. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10:572-578.
42. Piletz JE, Chikkala D, Khaitan L, Jackson K, Qu Y. 1993. Delayed desensitization of alpha 2-adrenoceptor-mediated platelet aggregation in depressed patients. Neuropsychopharmacology 9:55-66.
43. Pliszka DR, McCracken JT, Maas JW. 1996. Catecholamines in attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 35:264-272.
44. Rasmussen ER, Neuman RJ, Heath AC, Levy F, Hay DA, Todd RD. 2004. Familial clustering of latent class and DSM-IV defined attention-deficit/ hyperactivity disorder (ADHD) subtypes. J Child Psychol Psychiatry 45:589-598.
45. Reimann IW, Britzelmeier C, Bieck PR. 1987. Intra-subject variability of platelet alpha 2-adrenoceptor binding sites in healthy volunteers. Methods Find Exp Clin Pharmacol 9:677-683.
46. Rietveld MJ, Hudziak JJ, Bartels M, van Beijsterveldt CE, Boomsma DI. 2004. Heritability of attention problems in children: Longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry 45:577-588.
47. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. 2003. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am J Med Genet Part B 120B:116-120.
48. S.A.G.E. Statistical Package for Genetic Epidemiology, S.A.G.E. 5.0. 2004. Computer program package available from the Department of Epidemiology and Biostatistics. Case Western Reserve University, Cleveland, Rammelkamp Center for Education and Research, MetroHealth Campus.
49. Shekim WO, Hodges K, Horwitz E, Glaser RD, Davis L, Bylund DB. 1984. Psychoeducational and impulsivity correlates of platelet MAO in normal children. Psychiatry Res 11:99-106.
50. 3H-yohimbine and personality variations in normals. Psychiatry Res 32:125-134.
51. Shekim WO, Bylund DB, Hodges K, Glaser R, Ray-Prenger C, Oetting G. 1994. Platelet alpha2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder. Neuropsychobiology 29:120-124.
52. Sheline YI, Black KJ, Bardgett ME, Csernansky JG. 1995. Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology 12:315-322.
53. Silberg J, Rutter M, Meyer J, Maes H, Hewitt J, Simonoff E, Pickles A, Loeber R, Eaves L. 1996. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry 37:803-816.
54. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. 2000. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39:1432-1437.
55. Thapar A, Holmes J, Poulton K, Harrington R. 1999. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105-111.
56. Todd RD, Joyner CA, Ji TH, Sun L, Reich W, Neuman RJ. 2004. Family factors and sampling approach differentially influence attention deficit/hyperactivity disorder subtypes. Mol Psychiatry 9:260-263.
57. Viggiano D, Vallone D, Ruocco LA, Sadile AG. 2003. Behavioral, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev 27:683-689.
58. Viggiano D, Ruocco LA, Arcieri S, Sadile AG. 2004. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast 11:133-149.
59. Wang B, Wang Y, Zhou R, Li J, Qian Q, Yang L, Guan L, Faraone SV. 2006. Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet Part B 1416:130-134.
60. Wechsler D. 2005. Wechsler Intelligence Scale for Children. 3rd edn. San Antonio, TX: Psychological Corporation.
61. Wirz-Justice A. 1988. Platelet research in psychiatry. Experientia 44:145-152.
62. Xu C, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL, Barr CL. 2001. Linkage study of the alpha-2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105:159-162.
63. Young A. 1995. Genetic Analysis System (GAS). Oxford, England: Oxford University.